Antitumour platform comes of age: this system gets the responsible drug to keep itself in check for transport and delivery.
Antitumour platform comes of age: this system gets the responsible drug to keep itself in check for transport and delivery.
March’s Advanced Healthcare Materials covers
The application and the clinical development of nanomedicines strongly requires a deep study on the complex dynamics that happen after in vivo administration. Particularly, plasma proteins tend to associate to nanoparticles, forming a new surface named the “protein corona” that can have a strong impact on biodistribution, targeting efficacy, and toxicity.
Researchers have developed a controlled-release drug delivery system that uses focused ultrasound as an active induction method.
A nanophotonic approach makes ultrathin CIGSe solar cells with high efficiencies possible.
A manufacturing method is unveiled that uses a supportive material that is self-healing, and enables the production of soft materials in a supported and suspended manner.
Superamphiphobic and durable coatings on woven/non-woven surfaces for repelling many types of liquids.
Current advances in that latest progress in shifting the upconversion excitation wavelengths of lanthanide doped upconversion nanoparticles to a biological “sweet spot” of 800nm.
A detailed protocol to assess microRNA function in explanted organs is presented.
Research highlights from this month’s Advanced Healthcare Materials issues.